Laboratory Corp. of America Holdings
The 10-second takeaway
For the quarter ended June 30 (Q2), Laboratory Corp. of America Holdings met expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded slightly and GAAP earnings per share improved significantly.
Gross margins dropped, operating margins dropped, net margins improved.
Laboratory Corp. of America Holdings booked revenue of $1.42 billion. The 19 analysts polled by S&P Capital IQ predicted sales of $1.44 billion on the same basis. GAAP reported sales were 1.4% higher than the prior-year quarter's $1.40 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.77. The 20 earnings estimates compiled by S&P Capital IQ anticipated $1.79 per share. GAAP EPS of $1.56 for Q2 were 30% higher than the prior-year quarter's $1.20 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 40.7%, 120 basis points worse than the prior-year quarter. Operating margin was 19.6%, 30 basis points worse than the prior-year quarter. Net margin was 10.8%, 200 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.44 billion. On the bottom line, the average EPS estimate is $1.75.
Next year's average estimate for revenue is $5.70 billion. The average EPS estimate is $6.96.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 679 members out of 696 rating the stock outperform, and 18 members rating it underperform. Among 204 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 202 give Laboratory Corp. of America Holdings a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Laboratory Corp. of America Holdings is hold, with an average price target of $95.66.
- Add Laboratory Corp. of America Holdings to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Motley Fool newsletter services have recommended buying shares of Laboratory of America Holdings. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.